Discovery of ASP6918, a KRAS G12C Inhibitor: Synthesis and Structure-Activity Relationships of 1-{2,7-diazaspiro[3.5]non-2-yl} Prop-2-en-1-one Derivatives As Covalent Inhibitors with Good Potency and Oral Activity for the Treatment of Solid Tumors
Bioorganic & medicinal chemistry(2023)
Key words
KRAS G12C mutation,Non -small cell lung cancer,Structure -based drug design,Hydrophobic pocket,Steric hindrance,Oral activity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined